Inactive Instrument

Mymetics Corp Share Price OTC Bulletin Board

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

20/11/23	Mymetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
18/08/23	Mymetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.

Employees

Sector

Biotechnology & Medical Research

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	439K 380K 354K 325K 612K 41.76M 621K 4.16M 1.63M 20.93M 1.65M 1.61M 69.19M	P/E 2021	-1.86x	P/E 2022	-1.77x
Enterprise Value	72.12M 62.39M 58.26M 53.44M 101M 6.86B 102M 684M 268M 3.44B 271M 265M 11.37B	EV / Sales 2021	177x	EV / Sales 2022	78x
Free-Float	99.88%	Yield 2021 *	-	Yield 2022	-

20/11/23	Mymetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
18/08/23	Mymetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
15/05/23	Mymetics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
11/04/23	Mymetics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	CI
10/04/23	Mymetics Corporation Auditor Raises 'Going Concern' Doubt	CI
17/01/23	Mymetics Corporation Appoints Marcel B. Rüegg to the Board	CI
28/12/22	Mymetics Corporation Announces Resignation of Ernest M. Stern as A Member of the Board of Directors	CI
14/11/22	Mymetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
11/08/22	Mymetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
13/05/22	Mymetics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
31/03/22	Mymetics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	CI
30/03/22	Mymetics Corporation Auditor Raises 'Going Concern' Doubt	CI
12/11/21	Mymetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI

11/04/23	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
27/02/23	MYMETICS CORP : Other Events (form 8-K)	AQ
08/02/23	MYMETICS CORP : Other Events (form 8-K)	AQ
17/01/23	MYMETICS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
28/12/22	MYMETICS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+8.49%	+20.55%	+69.74%	+109.30%	68.12B
ARGENX SE	+1.25%	+2.44%	+32.55%	+72.63%	55.18B
INSMED INCORPORATED	-1.09%	+32.96%	+19.95%	+499.45%	28.63B
BIONTECH SE	+2.72%	+3.41%	-15.88%	-4.90%	23.53B
WUXI BIOLOGICS (CAYMAN) INC.	+10.83%	+18.38%	+52.76%	+4.58%	23.99B
GENMAB A/S	+6.50%	+7.56%	+38.20%	-21.33%	18.45B
PHARMAESSENTIA CORPORATION	-3.88%	+16.98%	+199.30%	+354.30%	15.83B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.20%	+11.51%	+34.94%	+681.88%	16.44B
EXELIXIS, INC.	+3.58%	+1.96%	+44.61%	+167.01%	13.4B
Average	+3.84%	+11.68%	+52.91%	+206.99%	29.28B
Weighted average by Cap.	+4.36%	+13.10%	+49.48%	+168.49%

	2021	2022
Net sales	430K 372K 347K 319K 599K 40.92M 609K 4.08M 1.6M 20.51M 1.61M 1.58M 67.81M	1.03M 889K 830K 762K 1.43M 97.84M 1.46M 9.74M 3.82M 49.04M 3.86M 3.78M 162M
Net income	-4.73M -4.09M -3.82M -3.51M -6.59M -450M -6.7M -44.83M -17.59M -226M -17.76M -17.37M -746M	-4.8M -4.16M -3.88M -3.56M -6.7M -457M -6.8M -45.54M -17.87M -229M -18.04M -17.65M -758M
Net Debt	67.1M 58.04M 54.2M 49.72M 93.52M 6.39B 95.01M 636M 250M 3.2B 252M 246M 10.58B	71.68M 62.01M 57.9M 53.12M 99.91M 6.82B 101M 679M 267M 3.42B 269M 263M 11.3B

Mymetics Corp Share Price OTC Bulletin Board

Stocks

Biotechnology & Medical Research

Valuation: Mymetics Corp

Latest news : Mymetics Corp

Press Releases: Mymetics Corp

Managers and Directors: Mymetics Corp

Bio Therapeutic Drugs

Financials

Company Profile